KBC Group’s AtriCure ATRC Stock Holding History

KBC Group’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$83K	Hold	1,484	–	–	﹤0.01%	1495
2026 Q2	$42K	Hold	1,484	–	–	﹤0.01%	1756
2026 Q1	$42K	Hold	1,484	–	–	﹤0.01%	1714
2025 Q4	$59K	Hold	1,484	–	–	﹤0.01%	1578
2025 Q3	$52K	Hold	1,484	–	–	﹤0.01%	1635
2025 Q2	$49K	Sell	1,484 -876	-37%	-$28.5K	﹤0.01%	1612
2025 Q1	$76K	Hold	2,360	–	–	﹤0.01%	1623
2024 Q4	$72K	Buy	2,360 +932	+65%	+$30K	﹤0.01%	1718
2024 Q3	$40K	Hold	1,428	–	–	﹤0.01%	1781
2024 Q2	$33K	Buy	1,428 +270	+23%	+$6.23K	﹤0.01%	1796
2024 Q1	$35K	Hold	1,158	–	–	﹤0.01%	1710
2023 Q4	$41K	Hold	1,158	–	–	﹤0.01%	1658
2023 Q3	$51K	Buy	+1,158	New	+$56.5K	﹤0.01%	1427

Other funds holding ATRC

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return

GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return

Neuberger Berman Group New York $148B AUM 31.56% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $102B AUM 35.16% 1-Year Est. Return

KBC Group's ATRC Position: Q3 2026 in Review

KBC Group held its AtriCure (ATRC) position steady in Q3 2026 at 1,484 shares worth $83K. The position accounts for ﹤0.01% of the portfolio, ranked #1495.

KBC Group first reported a position in ATRC in Q3 2023 and has held it in 13 quarters since. 221 funds tracked by Wall St. Rank hold ATRC as of Q3 2026.

KBC Group held 1,484 shares of AtriCure worth $83K as of Q3 2026.
KBC Group left its AtriCure share count unchanged in Q3 2026.
AtriCure made up ﹤0.01% of KBC Group's portfolio in Q3 2026, its #1495 holding.
KBC Group first reported a position in AtriCure in Q3 2023 and has held it in 13 quarters since.
221 funds tracked by Wall St. Rank held AtriCure as of Q3 2026.

Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.